Financials
- Financial year
- 2025
- Total assets
- €3.6m
- Profit
- €60,103
- Solvency
- 31.1%
Total assets▲ 0.6%
Net result
20182025
Summary
HENRY PHARMA is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.1m and a net result of €60,103. Equity is growing by about 4.6% per year across the filed financial years. Its solvency ranks better than 25% of 3,015 sector peers (NACE 64, financial year 2025). The company has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Activity
Activities of holding companies
NACE 64210
1 site
Size
€3.6mtotal assets 2025
- Equity
- €1.1m
- Profit
- €60,103
Financial health
Financial institution: outside the modelBankruptcy probability: sector outside the model
Structure
- Holdings
- 1
2025 accounts 60 days early3 deeds in the Belgian Official Gazette
SignalsneutralLatest accounts filed on timeShow the evidence
Checked score
Outside the general model
Model not applicable to financial institutions
The Checked score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Bankruptcy probability, 12 months
This is a financial institution (bank, insurer or financial holding). A bank balance sheet works differently from that of an ordinary trading or manufacturing company. We therefore show no bankruptcy probability rather than a misleading figure.
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
1 signal.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-06-2026, 60 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
60 days early
2024
7 days late
2023
28 days early
2022
32 days early
2021
45 days early
2020
38 days early
2019
56 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 36 days before the deadline; the sector median (NACE 64) for financial year 2024 is 14 days before the deadline, and 28% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
27-10-2026 today31-12-2026 year end31-07-2027 deadline
- Annual accounts filedfinancial year 2025 · full…
- Annual accounts filedfinancial year 2024 · full…
- Equity above €1mequity €1.1m ▲7%
Key points
By topic
Network & group
- Subsidiaries
- 1
1 subsidiary
Timeline
- Events
- 10
- Since
- 2019
- Next accounts
- by 31-07-2027
- 03-07-2024Annual accounts filed
- 31-12-2023Highest result from 2018 to 2025
- 29-06-2023Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company (pre-2019)
- Activity
- Activities of holding companiesNACE 64210
- Founded
- 25-01-2018
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Key facts about HENRY PHARMA
- What is the company number of HENRY PHARMA?
- 0688.865.294. In Belgium the VAT number is the company number with BE in front: BE 0688.865.294.
- Where is HENRY PHARMA based?
- The registered office is at Rue Roosevelt(LUT) 29, 6238 Pont-à-Celles.Company details
- What does HENRY PHARMA do?
- According to the KBO register, the main activity is activities of holding companies (NACE 64210).
- What is the legal form of HENRY PHARMA?
- Private limited company (pre-2019) (BVBA).
- When was HENRY PHARMA founded?
- On 25-01-2018.
- Is HENRY PHARMA still active?
- Yes, HENRY PHARMA is an active enterprise in the KBO register.
- What is the turnover of HENRY PHARMA?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
- Is HENRY PHARMA profitable?
- In financial year 2025, HENRY PHARMA made a profit of €60,103.
- Where can I find the annual accounts of HENRY PHARMA?
- HENRY PHARMA filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of HENRY PHARMA due?
- By 31-07-2027, for financial year 2026.Timeline
Companies related to HENRY PHARMA
Subsidiaries and holdings
- PHARMACIE HENRY100%
Comparable companies
- VERPACTRoeselare
- LAPYCKRoeselare
- H MANAGEMENTWavre
- BAVSOostende
- B &B verzekeringenOudenaarde
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What changed in the latest annual accounts?What changed What were this company's board, registered office and name on a given date?Company as of a date
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.